CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
testosteronedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00182871
NCT00182871Phase 4Completed
CompareCT.gov

Testosterone Effects on Bone and Frailty in Men With Osteoporosis

National Institute on Aging (NIA)·interventional·Posted Sep 16, 2005·Updated Oct 30, 2009

In Brief

A Phase 4 clinical trial evaluating testosterone for Aging and 2 related conditions. Completed, across 1 site.

Detailed Summary

The purpose of this study is to assess the effects of testosterone replacement on bone density, muscle strength, physical performance, quality of life and prostate symptoms in men selected for low bone mineral density or fracture and some aspect of frailty.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAging, Frailty, Osteoporosis
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 16, 2005
Enrollment StartNov 1, 2001
Primary CompletionJul 1, 2007
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 20.8 years ago

Interventions

testosteronedrug